Free Trial

Apellis Pharmaceuticals (APLS) SEC Filings & 10K Form

Apellis Pharmaceuticals logo
$35.09 -0.33 (-0.93%)
(As of 12:21 PM ET)

Recent Apellis Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/22/2024
3:16 PM
Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
11/22/2024
7:47 AM
Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G
11/08/2024
4:31 PM
Apellis Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
11/08/2024
9:52 AM
Apellis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/05/2024
5:57 AM
Apellis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
5:43 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:15 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
3:20 PM
Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:21 PM
Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
2:22 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
2:16 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
3:13 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
6:06 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
6:02 AM
Apellis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/21/2024
6:34 PM
Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:50 PM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
7:09 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
4:15 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
4:13 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
6:02 AM
Apellis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/19/2024
6:27 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:25 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:17 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2024
10:24 AM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
4:18 PM
Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
11:53 AM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
2:22 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2024
3:36 PM
Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/08/2024
6:45 AM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
12:37 PM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:10 PM
Apellis Pharmaceuticals (Filer)
Form 10-K/A
02/27/2024
6:35 AM
Apellis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
6:30 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
6:01 AM
Apellis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
4:18 PM
Apellis Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
02/14/2024
8:23 AM
Apellis Pharmaceuticals (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G/A
02/12/2024
2:19 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:22 PM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:27 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:28 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:43 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
My most important prediction yet (Ad)

One year ago at this time, I was gearing up to do something I’d never done before… After years of working behind the scenes, helping Tom Busby and teaching traders all about the markets, I was about ready to jump in front of a camera. Why? Because my research and years of expertise were showing me a phenomenon that people NEEDED to know about. That gold was setting up to go on a historic run that I called the “2024 Gold Supercycle.” I went LIVE on December 7, 2023, and made my bold prediction — staking 20+ years of a reputation on this one public prognostication. And the rest, as they say, is history… Gold went on to have its best year since 1979 — almost half a century! I’m going to tell you all about it on Wednesday, December 4th @ 1:00 PM ET, 362 days after I first made my prediction on gold.

Go here and finish your registration to receive your access link
02/12/2024
2:46 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
3:34 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:36 PM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:38 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:23 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:26 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:28 PM
Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:31 PM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
9:50 AM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
9:04 AM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2024
2:15 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2024
2:15 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2024
2:16 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2024
2:16 PM
Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2024
2:17 PM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2024
2:19 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
6:28 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
5:13 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
5:15 PM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
5:17 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
5:00 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
5:01 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
5:03 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
5:05 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
5:07 PM
Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
5:11 PM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
11:36 AM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
9:21 AM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:33 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:34 PM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:14 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:18 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:18 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:19 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:21 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:21 PM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:21 PM
Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:23 PM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
7:00 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
3:54 PM
Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:55 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:47 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:37 PM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:38 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:40 PM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:41 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:43 PM
Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:45 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:32 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:33 PM
Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]
01/17/2024
3:36 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
11:24 AM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
9:46 AM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2024
9:18 AM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2024
2:48 PM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2024
2:49 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2024
2:50 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2024
2:51 PM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2024
2:53 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:APLS) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners